Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

The summary for the Capacity Building for National Immunization Programs in the Eastern Mediterranean Region grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region: The purpose of this NOFO is to strengthen capacity and performance of national immunization programs in countries of the Eastern Mediterranean Region (EMR) to achieve regional vaccine preventable disease (VPD) control, elimination and eradication targets (i.e., polio eradication, measles and rubella elimination), reduce VPD-related morbidity and mortality, and address emerging public health threats such as coronavirus disease 2019 (COVID-19). The Recipient will strengthen the capacities to prevent, detect, and respond to VPDs s in EMR countries, including immunization service delivery, comprehensive VPD surveillance, and capacity needed to prepare for, detect, and respond to VPD outbreaks . The recipient will develop and implement targeted strategies to improve access to and coverage among high-risk un- and under-immunized populations. The recipient will also work to foster immunization program sustainability (i.e., evidence-based decision making through National Immunization Technical Advisory Groups (NITAGs), immunization safety, and workforce capacity), and advance program evaluation to innovate for increased immunization program impact (i.e., identify and address key immunization program challenges, use of evidence to guide immunization policy). This work will be critical to control of COVID19 and lay the groundwork for coronavirus vaccine introduction. This agreement may also support activities to address other global health priorities in line with CDC goals.